Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus
Head and Neck Diseases Conflux · 2025
DOI: 10.71321/5nx25d85 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head and Neck Diseases Conflux, 2025. Verfasst von Shanwen Chen und 7 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in combination with retroauricular glucocorticoid injection for the treatment of chronic tinnitus.
Methods
This prospective, single-arm study enrolled a total of 34 patients with chronic tinnitus. All participants received combined therapy consisting of taVNS and subcutaneous triamcinolone acetonide injection at the retroauricular mastoid sieve area. The interventions were administered over a one-month period, with taVNS delivered twice daily. Assessments were performed at three time points: baseline (T0), immediately post-treatment (T1), and one month after treatment completion (T2). The primary outcome was tinnitus severity, measured using the Tinnitus Functional Index (TFI). Secondary outcomes included sleep quality (Insomnia Severity Index, ISI), anxiety (Generalized Anxiety Disorder-7, GAD-7), and depression (Patient Health Questionnaire-9, PHQ-9).
Results
Significant improvements in tinnitus severity were observed, as reflected by a reduction in TFI scores from baseline to T1 (P = 0.002), with sustained improvement at T2 (P = 0.054). ISI scores also showed significant improvement from T0 to T1 (P = 0.033), with further improvement at T2 (P = 0.011). Although GAD-7 and PHQ-9 scores did not show immediate improvement post-treatment, both decreased significantly by T2 compared with baseline (GAD-7: P = 0.001; PHQ-9: P = 0.004), indicating delayed but meaningful reductions in anxiety and depressive symptoms.
Conclusion
The combined application of taVNS and retroauricular glucocorticoid injection yielded significant reductions in tinnitus severity. While additional controlled studies are warranted, these results offer preliminary evidence that this non-invasive approach may represent a promising therapeutic strategy for chronic tinnitus.
Zitieren
APA
Chen, S., Han, Y., Liu, Y., Li, J., Shen, Q., Li, Y., Tian, C., & Liu, Y. (2025). Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus. Head and Neck Diseases Conflux. https://doi.org/10.71321/5nx25d85
Vancouver
Chen S, Han Y, Liu Y, Li J, Shen Q, Li Y, et al. Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus. Head and Neck Diseases Conflux. 2025. doi:10.71321/5nx25d85
BibTeX
@article{Chen2025,
author = {Chen, Shanwen and Han, Yanxun and Liu, Yuchen and Li, Jiaxin and Shen, Qiling and Li, Yichen and Tian, Chunhui and Liu, Yehai},
title = {Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus},
journal = {Head and Neck Diseases Conflux},
year = {2025},
doi = {10.71321/5nx25d85}
}
EUVIMED